Clinical Trial Update: Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of ABT-267 in healthy volunteers and Hepatitis C virus infection (genotype 1) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-267

Snippet

Sponsor: Abbott | Conditions: HCV Infection | Phase 1 | Status: COMPLETED